Bejelentkezés Regisztrálj ingyen

4SC AG Intézményi tulajdon

Mi az 4SC AG Intézményi tulajdon?

A Intézményi tulajdon az 4SC AG - 3.04%

Mi a Intézményi tulajdon meghatározása?



Az intézményi tulajdonság a kölcsönös vagy nyugdíjpénztárak, biztosítótársaságok, befektetési vállalkozások, alapítványok vagy más, a mások nevében pénzeszközöket kezelő nagyvállalatok tulajdonában lévő, rendelkezésre álló állomány összege.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Intézményi tulajdon a Health Care szektor a XETRA-on cégekben a 4SC AG -hoz képest

Mit csinál 4SC AG?

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

intézményi tulajdon -hoz hasonló cégek 4SC AG